Kenneth Cornetta

  • 7955 Citations
  • 45 h-Index
1977 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Kenneth Cornetta is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles
Genetic Therapy Medicine & Life Sciences
Genes Medicine & Life Sciences
Retroviridae Medicine & Life Sciences
Hematopoietic Stem Cells Medicine & Life Sciences
Bone Marrow Medicine & Life Sciences
Lentivirus Medicine & Life Sciences
Bone Marrow Transplantation Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

NIH Grants 1977 2017

Product Packaging
Cell Line
Ross River virus
Inborn Genetic Diseases
Licensure
Genetic Therapy
Organized Financing
Competitive Bidding
Cell- and Tissue-Based Therapy
Ethicists
Genetic Therapy
Cell- and Tissue-Based Therapy
Organized Financing
National Heart, Lung, and Blood Institute (U.S.)
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
Genetic Therapy
Genes
Databases
Computational Biology
Clinical Trials
Genetic Therapy
Research Personnel
Databases
Toxicology
Genes

Publications 1979 2020

Replication-Competent Lentivirus Analysis of Vector-Transduced T Cell Products Used in Cancer Immunotherapy Clinical Trials

Cornetta, K., Koop, S., Nance, E., House, K. & Duffy, L., Jan 1 2020, Methods in Molecular Biology. Humana Press Inc., p. 181-194 14 p. (Methods in Molecular Biology; vol. 2086).

Research output: Chapter in Book/Report/Conference proceedingChapter

Lentivirus
Immunotherapy
Clinical Trials
T-Lymphocytes
Neoplasms

Gene Transfer to HSCs: Finding the Leukemia in Murine Leukemia Viruses

Cornetta, K., Jan 1 2019, In : Molecular Therapy.

Research output: Contribution to journalShort survey

Murine Leukemia Viruses
Leukemia
Genes
2 Citations (Scopus)

Ind-enabling studies for a clinical trial to genetically program a persistent cancer-targeted immune system

Puig-Saus, C., Parisi, G., Garcia-Diaz, A., Krystofinski, P. E., Sandoval, S., Zhang, R., Champhekar, A. S., McCabe, J., Cheung-Lau, G. C., Truong, N. A., Vega-Crespo, A., Komenan, M. D. S., Pang, J., Macabali, M. H., Saco, J. D., Goodwin, J. L., Bolon, B., Seet, C. S., Montel-Hagen, A., Crooks, G. M. & 17 others, Hollis, R. P., Campo-Fernandez, B., Bischof, D., Cornetta, K., Gschweng, E. H., Adelson, C., Nguyen, A., Yang, L., Witte, O. N., Baltimore, D., Comin-Anduix, B., Kohn, D. B., Wang, X., Cabrera, P., Kaplan-Lefko, P. J., Berent-Maoz, B. & Ribas, A., Feb 1 2019, In : Clinical Cancer Research. 25, 3, p. 1000-1011 12 p.

Research output: Contribution to journalArticle

T-Cell Antigen Receptor
Immune System
Clinical Trials
Hematopoietic Stem Cells
Neoplasms
23 Citations (Scopus)

Absence of Replication-Competent Lentivirus in the Clinic: Analysis of Infused T Cell Products

Cornetta, K., Duffy, L., Turtle, C. J., Jensen, M., Forman, S., Binder-Scholl, G., Fry, T., Chew, A., Maloney, D. G. & June, C. H., Jan 3 2018, In : Molecular Therapy. 26, 1, p. 280-288 9 p.

Research output: Contribution to journalArticle

Lentivirus
T-Lymphocytes
Safety
Genetic Therapy
Lentivirus Infections
1 Citation (Scopus)

Equitable Access to Gene Therapy: A Call to Action for the American Society of Gene and Cell Therapy

Cornetta, K., Patel, K., Wanjiku, C. M. & Busakhala, N., Jan 1 2018, (Accepted/In press) In : Molecular Therapy.

Research output: Contribution to journalArticle

Cell- and Tissue-Based Therapy
Genetic Therapy